Group
From University of La Laguna, at the ITB (Instituto de Tecnologías Biomédicas)
Tenerife – Spain
Esteban Porrini
- Professor of Nephrology at the University of La Laguna (Canary Islands)
- Researcher of the Ramón y Cajal Program of the Instituto de Salud Carlos III
- Past-President of the working group DIABESITY of the European Renal Association (ERA)
- Main areas of research include:
- the relevance of measured GFR in clinical practice and research
- renal disease in obesity, metabolic syndrome and diabetes
- post-transplant diabetes mellitus
- lipidomic analysis in renal disease
Ana Elena Rodríguez Rodríguez
Sergio Luis Lima
Laura Díaz Martín
Silvia Teixidó Trujillo
Jano DiCroce
Raúl Morales Febles
Olav River Martín
Aaron Afonso Alí
Federico González Rinne
From Oslo University
Oslo – Norway
Trond Geir Jenssen
- Born June 5, 1955. Consultant at The Department of Transplant Medicine, Kideny Section, University Hospital of Oslo, Rikshospitalet. Professor of Nephrology, University of Oslo
- Since 2018: Leader of the Research Group of Transplantation Medicine, University Hospital of Oslo, Rikshospitalet. Since 2003: Medical Advisor of the Norwegian Diabetes Association. 1995-1996: President of the Scandiavian Society for the Study of Diabetes. 1999-2001: President of the Norwegian Society of Nephrology.
- 2020: Recipient of the Norwegian Association of Diabetes Research Award.
- As of June 2023 author and co-author of 320 peer-reviewed publications.
- Citations (June 2023): 17.776. h-index 65. i10-index 225.
Web: https://www.med.uio.no/klinmed/personer/vit/trondjen/index.html
Anders Aasber
From Rigshospitalet – Copenhagen University
Copenhagen – Denmark
Mads Hornum
- Professor of Nephrology at University of Copenhagen
- Head of Research Laboratory for Medical Kidney Diseases at Copenhagen University Hospital Rigshospitalet.
- His research group has been focusing on clinical research in chronic kidney diseases (CKD), acute kidney injury (AKI) and solid organ transplantation, epidemiology, pathophysiological mechanisms, prediction, prevention, diagnostics and biomarkers.
- Monitoring and treatment of CKD and AKI has our special interest with special attention to diabetes and cardiovascular complications.
- Another focus is gastrointestinal hormones, bile acids and liver metabolism in persons with CKD and diabetes, and glucose/arrythmia/blood volume monitoring of diabetic and non-diabetic persons with CKD stage 3-5 or receiving dialysis treatment.